Targeting Tumor Necrosis Factor-α with Adalimumab: Effects on Endothelial Activation and Monocyte Adhesion

OBJECTIVE: It is well known that atherosclerotic inflammatory vascular disease is critically driven by oxidized lipids and cytokines. In this regard, tumor necrosis factor (TNF)-α is known as a crucial mediator of early pro-atherosclerotic events. Epidemiologic data suggest that blockade of TNF-α ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Oberoi, Raghav, Schuett, Jutta, Schuett, Harald, Koch, Ann-Kathrin, Luchtefeld, Maren, Grote, Karsten, Schieffer, Bernhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4965117/
https://www.ncbi.nlm.nih.gov/pubmed/27467817
http://dx.doi.org/10.1371/journal.pone.0160145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4965117/
https://www.ncbi.nlm.nih.gov/pubmed/27467817
http://dx.doi.org/10.1371/journal.pone.0160145

Ejemplares similares